Molecular Signatures for Diagnosing Scleroderma

The present invention features methods for classifying, determining severity, and predicting clinical endpoints of scleroderma based upon the expression of selected biomarker genes.

Attached files:
WO 2010008543.jpg

Patents:
WO 2,010,008,543

Inventor(s): WHITFIELD MICHAEL L [US]; SARGENT JENNIFER L [US]; PENDERGRASS SARAH A [US]; MILANO AUSRA [US]

Type of Offer: Licensing



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent